Skip to content

Effectiveness of Treatment With Rich Platelet Fibrin (PRF) VS Gold Standard in Patients Undergoing Knee Replacement

Effectiveness of Treatment With Rich Platelet Fibrin (PRF) VS Gold Standard in the Healing Process of Surgical Wounds in Patients Undergoing Knee Replacement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04165863
Acronym
Fibrin4Fast
Enrollment
12
Registered
2019-11-18
Start date
2020-01-20
Completion date
2021-11-04
Last updated
2022-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Disease

Brief summary

Randomized controlled single blind trial for the evaluation of the treatment of the surgical wound healing process with Platelet-Rich-Fibrin compared to the gold standard (without Platelet-Rich-Fibrin) in patients undergoing knee replacement.

Interventions

PROCEDUREtotal knee replacement surgery

total knee replacement surgery

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Males or females undergoing a total knee prosthesis. * Willingness and ability to comply with the study procedures and visit schedules and ability to follow verbal and written instructions. * Hb \> 11 g/dl; Platelet value \> 150.000 plt/mmc; * Patients with non clinical alteration of ECG; * Signature of informed consent;

Exclusion criteria

* Patients incapable of understanding and of wanting; * Systemic disorders such as diabetes, rheumatic diseases; * Patients with malignancy; * Thyroid metabolic disorders ; * Abuse of alcohol, drugs and pharmaceutical drugs * Body mass index \> 40;

Design outcomes

Primary

MeasureTime frameDescription
clinical improvement of the healing process2 weeksClinical improvement of the healing process, assessed by application of the Hollander Wound Evaluation Scales at 2 weeks of follow up

Secondary

MeasureTime frameDescription
Dermatology life quality3 days, 15 days and 1 monthDermatology life quality index improvement at 3 days, 15 days and 1 month

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026